NorthStar Medical Radioisotopes completed construction in July of 2019 on a 20,000-sf production facility in Beloit, Wis. Featuring the company's RadioGenix® System, the project features state-of-the-art dissolution and source vessel filling equipment for the processing of molybdenum-99 (Mo-99) to support the creation of technetium-99m (Tc-99m) for diagnostic imaging applications. The facility also houses a quality control lab, an automated packaging line, and an advanced molybdenum recycling complex. The production center was built by Corporate Contractors Incorporated to meet the standards of the U.S. Food and Drug Administration. Additionally, NorthStar Medical Radioisotopes will break ground in late 2019 on a 20,000-sf linear accelerator on its 32-acre Beloit campus.
